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Abstract
Background: Little is known about the inter-rater agreement of personality disorders in clinical
settings.
Methods: Clinicians rated 75 patients with substance use disorders on the DSM-IV criteria of
personality disorders in random order, and on rating scales representing the severity of each.
Results: Convergent validity agreement was moderate (range for r = 0.55, 0.67) for cluster B
disorders rated with DSM-IV criteria, and discriminant validity was moderate for eight of the ten
personality disorders. Convergent validity of the rating scales was only moderate for antisocial and
narcissistic personality disorder.
Discussion: Dimensional ratings may be used in research studies and clinical practice with some
caution, and may be collected as one of several sources of information to describe the personality
of a patient.
Background
Personality disorders [PD] represent a major challenge to
professionals dealing with substance abusers. PDs com-
plicate treatment for substance use disorders [1-3].
The PD categories and their criteria sets were developed by
committees of experts drawing upon their collective clini-
cal experience and insight. Revisions made to the PDs for
later revisions of the diagnostic manuals also followed
this committee/clinical-experience approach, and some
have argued that the committees responsible for the revi-
sion have not sufficiently considered the research that has
been conducted on the psychometric properties of PDs
[4]. But replacing rationally derived descriptions with
empirically derived alternatives may not solve the prob-
lem for researchers or clinicians working with substance
abusers. For instance, a study found that the longterm sta-
bility and congruence with observer rating was no better
for the empirically derived Five Factor Model than for PDs
in a sample of substance abusers [5].
The DSM-IV criteria are viewed as more clear and under-
standable than the DSM-III-R criteria by both laymen and
mental health professionals [6].
In clinical practice, most clinical psychologists use clinical
observation and deduction based on behaviour in the
clinic and clients narratives [7]. Some researchers also
argue for the utility of clinical observations [8], and use
clinical observations in studies of the psychometric prop-
erties of PDs [9,10], including predictive validity [11].
Other researchers argue for the use of self-report instru-
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[12], or for the use of semi-structured interviews [13],
such as the Structured Interview for the DSM-III-R PDs
[SIDP-R] [14], or the Structured Clinical Interview for the
DSM-IV [SCID-II] [15]. Yet other researchers argue for the
integration of information from a range of sources as the
gold standard of PD research [16,17]. Reliability research
has mostly supported interviews and self-report invento-
ries over clinical diagnoses. But clinical diagnoses have
mostly been studied as dichotomous yes/no diagnoses,
often with low base-rates of disorder, resulting in very
poor power to assess agreement [10].
In the nomenclature, PDs are considered categories. How-
ever, categorical approaches have produced a number of
problems. Comparisons of different structured interviews
have shown that while criteria counts correlate highly,
agreement about categorical diagnoses is often poor, sim-
ply because many subjects fall on either side of diagnostic
cut-offs on different interviews [18]. Thus, even though
the actual association of two instruments is about as
strong as one can expect to find in the field of psychiatry,
categorical diagnoses reduce reliability drastically [19]. An
alternative to the categorical approach is to see personality
disorders as dimensions, rather than categories.
A study on alcohol dependent patients using the Interna-
tional Diagnostic Checklists for Personality Disorders
after longterm clinical observation have noted high inter-
rater agreement of paranoid, antisocial, borderline, histri-
onic, narcissistic, avoidant, dependent and passive-
aggressive personality disorders [11]. A limitation to that
study was the requirement of three months of abstinence
in treatment before diagnoses could be conducted.
Requiring three months of abstinence can help raters
avoid misinterpretation of temporary withdrawal-related
dysfunctions as symptoms of personality disorders. But
given the pervasive negative impact of personality disor-
ders on retention and outcome, clinicians need to adjust
their treatment to the behavioural, cognitive and emo-
tional problems that patients experience at an early stage
in treatment, often before patients can even be detoxified.
A study on a mixed sample of abstinent and non-absti-
nent substance abusers [10] showed that correlations
between dimensional ratings of personality disorder
severity with rating scales for each personality disorder
resulted in moderate correlations for paranoid, schizo-
typal, antisocial, and borderline personality disorder, and
high-moderate discriminant validity was found for all per-
sonality disorders except schizoid and obsessive-compul-
sive personality disorder. A limitation of that study was
the exclusive reliance on the rating scales, which may have
reduced psychometric properties compared with specific
criteria for personality disorders.
A recent study by Bowden-Jones and colleagues showed
that clinical diagnosis of personality disorder resulted in
substantial underdiagnosis of personality disorders in a
sample of drug and alcohol abusers [20]. When requiring
clinicians to make diagnoses, some, more common and
well-known diagnoses may be over-rated, at the expense
of less common diagnoses [13,21].
Interrater agreement in terms of personality disorders can
be seen to reflect the reliability of personality disorder rat-
ings: if an observers' rating of a patients' personality disor-
der is used as an indicator of the presence of that
personality disorder, how certain can anyone be that a dif-
ferent observer under similar circumstances would give a
similar rating? However, from a different perspective,
interrater agreement can actually be seen as reflecting
validity: if a patient seems to be paranoid, schizoid, or
antisocial to two different clinicians, it can be seen as an
indication that the patient actually displays behaviour
consistent with the disorder. In this article, we approach
interrater agreement statistically as if it were validity (see
below for details). That is, we assess not only the magni-
Table 1: Descriptive statistics for the sample
Prevalence (over cut-
off for diagnosis with a






Standard deviation Mean score for
rating scales
Standard deviation
Paranoid 8% 0.79 5.2 3.1 38.9 20.4
Schizoid 5% 0.73 3.9 2.8 23.4 22.7
Schizotypal 1% 0.79 4.5 3.3 25.3 22.4
Antisocial 12% 0.81 4.8 3.3 37.9 26.9
Borderline 1% 0.72 6.4 3.5 35.3 22.2
Histrionic 3% 0.72 4.4 3.1 23.8 22.5
Narcissistic 5% 0.87 4.7 3.9 33.3 27.3
Avoidant 4% 0.81 4.9 3.1 29.6 23.5
Dependent 5% 0.80 5.9 3.7 30.6 24.4
Obs-Com 0% 0.72 3.8 2.9 31.0 26.0Page 2 of 6
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the correlations between unrelated constructs. The ration-
ale was that some patients could in principle receive high
ratings on all personality disorder criteria regardless of
which personality disorder the criterion belonged to,
whereas another patient could receive low ratings on all
criteria, regardless of what personality disorder that crite-
rion belonged to. This could result in high interrater cor-
relations, not because of agreement about the specific
personality disorder, but because of agreement concern-
ing the presence of personality disorder criteria in general.
Purpose of the study
The purpose of the study was to assess convergent and dis-
criminant interrater agrement of the rating scales. The
sample for the present study does not overlap with the
sample used in the previous study [10].
Methods
A mixed sample of 75 substance abusers and dual diagno-
sis patients were included in the study. Ten were from
methadone maintenance settings, and the remaining 65
were from various drug free treatment settings (i.e., resi-
dential or outpatient drug free treatment settings for illicit
drug use problems). Most (59) were men, and the mean
age was 33.7 years (standard deviation = 6.9).
Raters were clinicians (mostly social workers or addiction
counsellors; some psychologists or nurses) who were
actively involved in patients' treatment. The rating scales
used included ten rating scales with scores ranging from 0
to 100% representing the 10 DSM-IV personality disor-
ders [10], and the 79 criteria for the same personality dis-
orders listed in the DSM-IV manual [22]. The criteria were
listed in random order to avoid halo bias [9]. Scoring
options were 0 (no indication of presence of criterion), 1
(criterion present, but inconsistently, or not causing
impairment), and 2 (criterion present, consistently and
causing impairment). Based on these scorings, we pro-
duced scales that could range from 0 to 2 times the
number of criteria listed for the disorder.
All staff members included in the present analysis had
participated in training with at least two days of education
on PDs, and had been asked to read through a Danish
translation of the criteria for each of the 10 PDs provided
by one or both of the authors. In 26 of the ratings there
were more than 2 rating each patient. In these cases, two
were selected using random numbers. The final number
of clinicians included with the ratings were 63. Further, on
the first sheet of the form, clinicians indicated what kind
of contact they had had with patients (counseling, group
counseling, and unstructured millieu observation).
Construct validity was analyzed using traditional indices
[23]. Convergent and discriminant validity coefficients
were calculated as Pearson correlations. Convergent valid-
ity is measured as correlations between the same construct
measured with different raters, and discriminant correla-
tions denotes correlations between different constructs
measured either by the same rater or by different raters.
We also calculated the intraclass correlations coefficients
for convergent correlations.
Discriminant correlations that exceed convergent correla-
tions are termed comparison violations. That is, instances
where correlations between unrelated constructs exceed
correlations between related constructs. For each PD scale
18 same-rater discriminant correlations and 18 inter-rater
discriminant correlations were calculated from three 10
by 10 matrices (the matrices containing inter-rater, judge
1, and judge 2 correlations). We report the reliability
indexes by clusters, according to the DSM-IV (i.e., cluster
A, odd-ecccentric, paranoid, schizoid schizotypal; cluster
B, dramatic-erratic, antisocial, borderline, histrionic, nar-
cissistic; and cluster C, anxious-fearful, avoidant, depend-
ent, obsessive-compulsive [22]).
Table 2: Convergent and discriminant validity of DSM-IV criteria






Paranoid 0.45 < 0.001 29% 53% 5%
Schizoid 0.26 0.022 37% 37% 37%
Schizotypal 0.43 < 0.001 16% 32% 0%
Antisocial 0.55 < 0.001 18% 32% 5%
Borderline 0.55 < 0.001 21% 42% 0%
Histrionic 0.64 < 0.001 3% 5% 0%
Narcissistic 0.67 < 0.001 5% 11% 0%
Avoidant 0.29 0.008 39% 58% 21%
Dependent 0.43 < 0.001 13% 26% 0%
Obs-Com 0.47 < 0.001 8% 16% 0%Page 3 of 6
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[24], discriminant validity is considered high at less than
5% comparison violations, moderate at 5–33%, and low
at more than 33%. Convergent validity is considered high
at r > 0.70, moderate at 0.50–0.70, and minimal at 0.30–
0.50 [23]. Power analysis showed that the power to detect
moderate convergent validity was acceptable with a sam-
ple size of 76 (alpha set to 0.005 to adjust for multiple sig-
nificance tests, power = 0.97). The power to detect
marginal convergent validity was not acceptable, but the
scientific and clinical significance of agreement that is
only marginal is also limited.
Ethical committees in Denmark do not assess the ethical
appropriateness or otherwise of studies regarding proce-
dures except if the study involves invasive procedures or
the use of medications. However, to the best of our knowl-
edge, we have not violated the Declaration of Helsinki
[25] or other ethical issues in relation to the data collec-
tion for this study.
Results
From all ratings, 79% reported individual counseling con-
tact, 79% reported unstructured millieu observations, and
61% reported having had group counseling contact.
Almost half (49%) reported all three kinds of contact.
Prevalence of PD, mean scores and standard deviations on
each scale can be seen in table 1. Also reported is Cron-
bach's alpha, a measure of internal consistency for each
PD scale.
Convergent and discriminant validity of DSM-IV criteria
The correlations and percent comparison violations for
the DSM-IV criteria can be seen in table 2. In table 2 and
3, convergent correlations (i.e., correlations between two
different clinicians' ratings of the same patient on the
same construct) and unadjusted probablities of the corre-
lations are shown in column 2 and 3. The total number of
comparison violations is shown in column 4 (i.e., propor-
tion of correlations between the construct and any other
construct rated by either the same or a different clinican
that exceed the convergent correlation). The number of
comparison violations by the same rater is shown in col-
umn 5 (i.e., the proportion of correlations of the same cli-
nicians' ratings of the same patient on different constructs
that exceed the convergent correlation). The number of
comparison violations by the different raters is shown in
column 6 (i.e., the proportion of correlations between dif-
ferent clinicians' ratings of the same patient on different
constructs that exceed the convergent correlation).
Agreement was moderate for all cluster B disorders (range:
0.55, 0.67), and minimal or worse for all cluster A and C
disorders (range: 0.26, 0.47). Intraclass correlations did
not differ substantially from Pearson product-momemt
correlations (the highest difference was found for avoid-
ant personality disorder: r = 0.29, ICC = 0.32). Discrimi-
nant validity was moderate for paranoid, schizotypal,
dependent and obsessive-compulsive personality disorder
and all cluster B disorders (range of comparison viola-
tions: 5–21%).
By far the largest number of comparison violations were
same-rater violations (i.e., correlations between the same
rater's rating of the same patient on different personality
disorders exceeding different rater's rating of the same
patient on the same personality disorder). Only for schiz-
oid and avoidant personality disorders, there was a
number of discriminant violations.
Convergent and discriminant validity of rating scales
The correlations and percent comparison violations for
the DSM-IV criteria can be seen in table 3.
Agreement was moderate for antisocial (r = 0.65) and nar-
cissistic personality disorder (0.59), and minimal or
worse for all other disorders (range: 0.01, 0.49). Discrimi-
nant validity was moderate for paranoid, antisocial, histri-
onic, narcissistic, avoidant and obsessive-compulsive
disorders (range of comparison violations: 5–29%). The
Table 3: Convergent and discriminant validity of rating scales representing personality disorders






Paranoid 0.29 0.015 29% 42% 16%
Schizoid 0.19 0.069 47% 63% 32%
Schizotypal 0.04 0.496 74% 95% 53%
Antisocial 0.65 < 0.001 5% 11% 0%
Borderline 0.26 0.029 42% 68% 16%
Histrionic 0.49 < 0.001 13% 26% 0%
Narcissistic 0.59 < 0.001 5% 11% 0%
Avoidant 0.38 0.001 16% 32% 0%
Dependent 0.01 0.873 71% 95% 47%
Obs-Com 0.47 < 0.001 5% 11% 0%Page 4 of 6
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Pearson product-moment correlations. The highest differ-
ence was found for dependent PD (r = 0.02, ICC = 0.01).
Again, the largest number of comparison violations were
same-rater violations (i.e., correlations between the same
rater's rating of the same patient on different personality
disorders exceeding different rater's rating of the same
patient on the same personality disorder). Only for disor-
ders with very weak convergent validity, a number of com-
parison violations were found (i.e., schizoid, schizotypal
and dependent personality disorders).
Discussion
Clinicians in this sample rated personality disorders based
only on their knowledge of patients. Convergent and dis-
criminant correlations were mostly as good as convergent
and discriminant correlations based on interview vs. ques-
tionnaire conducted with the same patient [26,27], and
somewhat better than self/other agreement on personality
disorders [28]. When clinician ratings offer a reliable per-
spective on personality disorders, such observations may
add an important perspective to ratings of personality
pathology. Based on the current findings, it appears that
there is support for the reliability of staff observations of
8 of 10 disorders at the given level of alpha (0.005). The
exceptions, schizoid and avoidant personality disorders,
are both related to introversion [29] and interpersonal
withdrawal [22]. It may not be so easy to identify such
traits, especially in clinical contexts where many other
patients draw attention to themselves.
The use of dimensional scores increased the power of the
present study substantially. Having dichotomized diag-
noses would have led to low baserates (with a maximum
of 12 percent for antisocial personality disorder), and
would therefore almost certainly not have led to reasona-
ble agreement – eventhough the scales representing the
same traits showed statistically significant convergent cor-
relations for 8 of 10 personality disorders with the present
alpha.
The interrater agreement on personality disorders was bet-
ter for criterion-based ratings than for simple rating scales.
However, the difference was not large. The correlation of
raters' rating of personality disorders with another rater in
this sample ranged from 0.29 for schizoid personality to a
maximum of 0.67 for narcissistic personality disorder.
And while convergent validity was improved compared
with rating scales, the amount of high discriminant corre-
lations was still substantial. In particular, same-rater cor-
relations were in many cases larger than convergent
correlations. Thus, when a clinician rated a patient, he was
likely to either give high scores regardless of what person-
ality disorder was rated, or give low scores.
The utility of data sources depend on the purpose of
assessment. For certain research purposes, clinical obser-
vation may suffice, with the notable exception of schizoid
and avoidant traits.
Limitations
The study has some limitations due to the sample group:
The sample is heterogeneous with regard to substance and
level of substance intake. Therefore, some of the variabil-
ity in terms of personality disorder severity may be related
to variability in substance-related problems, especially
chronic substance-related problems. However, when the
patients were rated by clinicians, they were actively
involved in treatment, and the most acute substance-
related problems that could mimic personality disorders
would likely be reduced at this point.
A further limitation is that we did not collect information
about the number of contacts or the amount of time spent
with patients. We did have some information about the
type of contact.
Further studies of interrater agreement of comorbid per-
sonality disorders can benefit from including detailed
information on level and kind of drug intake as well as
conducting the rating at a certain point after beginning of
treatment. However, the method used resembles clinical
practice, where it is often not clear at the beginning of
treatment, what personality disorders a patient has, yet cli-
nicians make observations and judgments about patients'
long-standing problems and traits [7].
A further limitation was the absence of self-reported data
on personality disorders from a self-report inventory or a
semi-structured interview. The study could therefore only
rate to what extent two external observers would make the
same observations. On the other hand, semi-structured
interviews and inventories are susceptible to biases, both
in the form of impression management and patients' var-
ying degree of insight into their problems.
Conclusion
In conclusion, clinicians' ratings of personality disorders
are sufficiently reliable to constitute a source of informa-
tion about patients' personality disorders, with the excep-
tion of schizoid and avoidant personality disorder.
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